Study Uncovers Top Error in Weight-Loss Drug Use

Top Error in Weight-Loss Drug Use
Top Error in Weight-Loss Drug Use. Credit | Getty images

United States: They are stopping their weight-loss medication because they lost the weight, this sounds peculiar as a lot of people are having issues after taking the weight loss pills as they are having some health issues after consuming the medications.

Survey Findings

According to a new Blue Cross Blue Shield Association survey, the majority of patients on GLP-1 medications, such as Ozempic and Wegovy, do not stick to their prescribed course of action for at least 12 weeks; in fact, over 30% of patients stop taking the medication after just four weeks.

Demographic Trends

An review of 169,250 health insurance claims made between 2014 and 2023 revealed that those between the ages of 18 and 34 and those residing in underserved health districts had a higher likelihood of discontinuing treatment earlier. The authors of the report state that taking these medications “long enough to achieve clinical success” is “critical.”

Visual Representation of Weight-loss Drugs. Credit | FreeImages

1.7% of Americans were prescribed a semaglutide medication last year research shows.

According to the Department of Surgery at Columbia University, people who use these injectable medications typically lose 15% to 20% of their body weight, however only about 10% of users really lose that much.

Effectiveness and Side Effects

Studies have shown that most users of weight-loss medications quit within a year.

Dr. Steven Batash, a prominent physician at Batash Endoscopic Weight Loss, a Queens-based gastroenterologist, told Prevention last week that “users of these weight-loss medications typically stop taking them because they see results.”

Because of early side effects, people may discontinue treatment before the six-weekmark, according to the report’s authors. Constipation, puking, diarrhea, nausea, and stomach discomfort are typical adverse goods.

Costs also affect the vacuity of weight- loss specifics. These include copays, which are the one- time freights you pay for a medical visit or tradition, and coinsurance, which is the quantum you pay after your deductible is met.

Financial Barriers

Blue Cross Blue Shield Association. Credit | Getty images

Compared to those who pay more, those whose monthly expenses are less than $60 are much more likely to continue taking their medications. A survey from the Blue Cross Blue Shield Association states that the average monthly list price for semaglutide is more than $1,000.

Board-certified bariatric surgeon Dr. Michael Russo of Orange County, California, notes that his patients who discontinue their weight-loss medications early typically attribute it to the expense.

Russo stated to Prevention, “Just because something is covered by insurance doesn’t mean it’s not a prohibitive cost.”

Recommendations

The Blue Cross Blue Shield Association recommends that patients “complete at least 12 weeks of continuous treatment to achieve a level of weight loss that will positively impact their health,” regardless of the reason for the patient’s weight loss.

According to studies, people who stop taking their medications usually gain back two thirds of the weight they lost.

As long as patients take the drug as prescribed, these drugs have shown to be effective in treating obesity, according to Batash.